EMD has a great chance because of the data they own. IHL is not over valued at all, they target conditions with no approved treatment so getting FDA approval would be easier. The board is second to none.
- Forums
- ASX - By Stock
- EMD
- Ann: Global Pharmaceutical Expert joins Advisory Board
Ann: Global Pharmaceutical Expert joins Advisory Board, page-5
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.90M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.4¢ | $18.70K | 550.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 39378 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 42028 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 39378 | 0.033 |
4 | 251280 | 0.032 |
1 | 32258 | 0.031 |
1 | 17500 | 0.030 |
1 | 20000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 42028 | 1 |
0.035 | 237134 | 1 |
0.037 | 70000 | 1 |
0.039 | 120000 | 2 |
0.040 | 57647 | 1 |
Last trade - 10.59am 21/08/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online